Biotech Stocks Facing FDA Decision In January 2025
As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 novel drugs, matching the total from 2021 and making it the fourth-highest approval year. The highest number of novel drug …